News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

David de Graaf Appointed as a Scientific Advisory Board Member for Massachusetts Institute of Technology (MIT)’s Center for Cancer Systems Biology


9/12/2011 10:33:52 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa™, a personalized healthcare company focused on stratification of patients and development of predictive biomarker panels based on disease-driving mechanisms, today announced that the Company’s Chief Executive Officer, David de Graaf, has recently been appointed as a Scientific Advisory Board member for the MIT’s Center for Cancer Systems Biology (CCSB) in the National Cancer Institute’s Integrative Cancer Biology Program (ICBP).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES